Skip to main navigation

Overview
Press Releases
Events & Presentations
Corporate Governance
Financial Information
- SEC Filings
- Swiss Statutory Financial Statements and Audit Reports
Stock Information
Shareholder Services

Back to CRISPR »

Presentations

Presentations

Apr 2019

2019 American Association for Cancer Research (AACR) Annual Meeting Poster: Allogeneic CRISPR/Cas9 Gene-edited CAR-T Cells Targeting CD33 Show Potent Preclinical Activity Against AML Cells 564 KB

Dec 2018

2018 Annual Meeting of The American Society of Hematology (ASH) Poster: Preclinical Development of CTX120, an Allogeneic CAR-T Cell Product Candidate Targeting BCMA 1 MB

Nov 2018

2018 Annual Meeting of The Society for Immunotherapy of Cancer (SITC) Poster: CRISPR/Cas9 Enables the Efficient Production of Allogeneic CAR-T Cells Engineered to Contain Multiple Genome Edits to Enhance Therapeutic T Cell Function 654.9 KB

May 2018

2018 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting Poster: Allogeneic CAR-T Cells with Multiple Therapeutically Favorable Edits Can Be Created Efficiently Using CRISPR/Cas9 565.3 KB

Apr 2018

2018 American Association for Cancer Research (AACR) Annual Meeting Poster: Allogeneic CRISPR Engineered Anti-CD70 CAR-T Cells Demonstrate Potent Preclinical Activity Against Both Solid and Hematological Cancer Cells 566.9 KB

Apr 2018

2018 American Association for Cancer Research (AACR) Annual Meeting Poster: Allogeneic Chimeric Antigen Receptor T Cells Targeting B Cell Maturation Antigen 577.7 KB

Pagination

First page
Previous page
Page 1
Page 2
Page 3
Current page 4

Displaying 31 - 36 of 36

Shareholder Tools

Print Page
RSS Feeds
Email Alerts
Contact IR

Interested in joining our team? Careers at CRISPR

© 2023 CRISPR Therapeutics. Contact | Privacy Policy | Terms and Conditions